Patent · US Active

Agents for treating migraine

US7763625B2 · kind B2 · utility

1Cited by
10References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 28, 2005
Grant dateJul 27, 2010
Priority date
Expiry dateApr 12, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating migraine comprising administering, as an active ingredient, a xanthine derivative represented by the following formula or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.